• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Annual Changes to the Nasdaq-100 Index®

    12/12/25 8:00:00 PM ET
    $ALNY
    $BIIB
    $CDW
    $FER
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Get the next $ALNY alert in real time by email

    NEW YORK, Dec. 12, 2025 (GLOBE NEWSWIRE) -- Nasdaq (NASDAQ:NDAQ) today announced the results of the annual reconstitution of the Nasdaq-100 Index® (NDX®), which will become effective prior to market open on Monday, December 22, 2025.

    The following six companies will be added to the Index: Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY), Ferrovial SE (NASDAQ:FER), Insmed Incorporated (NASDAQ:INSM), Monolithic Power Systems, Inc. (NASDAQ:MPWR), Seagate Technology Holdings plc (NASDAQ:STX), Western Digital Corp. (NASDAQ:WDC).

    The Nasdaq-100 Index is a globally recognized index that tracks the performance of 100 of the largest non-financial companies listed on the Nasdaq Stock Market® encompassing a diverse range of industries and sectors. From technology and retail to healthcare, telecommunications, biotechnology, and media, these companies collectively shape the new 21st century economy. The Nasdaq-100® is reconstituted each year in December, timed to coincide with the quadruple witch expiration Friday of the quarter.

    As of December 2025, the Nasdaq-100 Index underpins more than 200 tracking products with over $600 billion in assets under management globally, including the Invesco QQQ Trust (QQQ®), which seeks to deliver investment results that, before expenses, correspond to the performance of the Nasdaq-100 Index. In addition to QQQ, a range of derivatives and structured instruments, such as futures, options, and other products based on the Nasdaq-100 Index and the Invesco QQQ Trust trade on various exchanges.

    As a result of the reconstitution, the following six companies will be removed from the Index: Biogen Inc. (NASDAQ:BIIB), CDW Corporation (NASDAQ:CDW), GlobalFoundries Inc. (NASDAQ:GFS), Lululemon Athletica Inc. (NASDAQ:LULU), ON Semiconductor Corporation (NASDAQ:ON), The Trade Desk, Inc. (NASDAQ:TTD).

    Information

    For information about the six companies to be added to the Nasdaq-100 Index, please visit the following respective company websites:

    • Alnylam Pharmaceuticals, Inc. – https://www.alnylam.com/
    • Ferrovial SE – https://www.ferrovial.com/
    • Insmed Incorporated – https://insmed.com/
    • Monolithic Power Systems, Inc. – https://www.monolithicpower.com/
    • Seagate Technology Holdings plc – https://www.seagate.com/
    • Western Digital Corp. – https://www.westerndigital.com/



    About Nasdaq Global Indexes

    Nasdaq Global Indexes has been creating innovative, market-leading, transparent indexes since 1971. Today, our index offering spans geographies and asset classes and includes diverse families such as the Dividend and Income (includes Dividend Achievers), Dorsey Wright, Fixed Income (includes BulletShares®), Global Equity, Green Economy, Nordic, and Commodity indexes. We continuously offer new opportunities for financial product sponsors across a wide spectrum of investable products and for asset managers to measure risk and performance. Nasdaq also provides exchange listing, custom index, and design solutions to financial organizations worldwide.

    About Nasdaq

    Nasdaq (NASDAQ:NDAQ) is a leading global technology company serving corporate clients, investment managers, banks, brokers, and exchange operators as they navigate and interact with the global capital markets and the broader financial system. We aspire to deliver world-leading platforms that improve the liquidity, transparency, and integrity of the global economy. Our diverse offering of data, analytics, software, exchange capabilities, and client-centric services enables clients to optimize and execute their business vision with confidence. To learn more about the company, technology solutions, and career opportunities, visit us on LinkedIn, on X @Nasdaq, or at www.nasdaq.com

    Nasdaq®, Nasdaq-100 Index®, Nasdaq-100®, NDX®, QQQ®, and Nasdaq Stock Market® are registered trademarks of Nasdaq, Inc. The information contained above is provided for informational and educational purposes only, and nothing contained herein should be construed as investment advice, either on behalf of a particular security or an overall investment strategy. Neither Nasdaq, Inc. nor any of its affiliates makes any recommendation to buy or sell any security or any representation about the financial condition of any company. Statements regarding Nasdaq-listed companies or Nasdaq proprietary indexes are not guarantees of future performance. Actual results may differ materially from those expressed or implied. Past performance is not indicative of future results. Investors should undertake their own due diligence and carefully evaluate companies before investing. ADVICE FROM A SECURITIES PROFESSIONAL IS STRONGLY ADVISED.

    Media Relations Contact Investor Relations Contact
    Name: Maximilian Leitenberger

    Email: [email protected]



     Name: Index Client Services

    Email: [email protected]

       

    NDAQF



    Primary Logo

    Get the next $ALNY alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ALNY
    $BIIB
    $CDW
    $FER

    CompanyDatePrice TargetRatingAnalyst
    The Trade Desk Inc.
    $TTD
    2/26/2026$17.00Neutral → Sell
    New Street
    The Trade Desk Inc.
    $TTD
    2/26/2026$25.00Buy → Hold
    Loop Capital
    Nasdaq Inc.
    $NDAQ
    2/26/2026$106.00Hold → Buy
    TD Cowen
    Biogen Inc.
    $BIIB
    2/20/2026$185.00Equal Weight
    Barclays
    ON Semiconductor Corporation
    $ON
    2/12/2026$75.00Equal Weight
    Barclays
    ON Semiconductor Corporation
    $ON
    2/10/2026Buy → Hold
    The Benchmark Company
    Biogen Inc.
    $BIIB
    2/9/2026$194.00 → $228.00Buy
    H.C. Wainwright
    Western Digital Corporation
    $WDC
    1/30/2026$200.00 → $325.00Buy
    TD Cowen
    More analyst ratings

    $ALNY
    $BIIB
    $CDW
    $FER
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    lululemon Responds to Chip Wilson's Statements

    lululemon athletica inc. (NASDAQ:LULU) ("lululemon" or the "company") today commented on Chip Wilson's press release in relation to his nomination of three director candidates to stand for election to the company's Board at lululemon's 2026 Annual Meeting of Shareholders: We have continued to engage with Mr. Wilson in good faith over the past few months, including numerous meetings, with the goal of having a productive dialogue with him. We disagree with Mr. Wilson's characterization of his interactions with the Board. The Board has repeatedly requested the opportunity to interview Mr. Wilson's director nominees. However, Mr. Wilson had indicated he would not allow the Board to meet wit

    2/27/26 11:39:00 AM ET
    $LULU
    Apparel
    Consumer Discretionary

    Chip Wilson Provides Update to lululemon Shareholders

    VANCOUVER, BC, Feb. 27, 2026 /CNW/ -- Chip Wilson, Founder of lululemon athletica inc. (NASDAQ:LULU) ("lululemon" or the "Company") and one of lululemon's largest shareholders, today released the following letter to lululemon shareholders: Shareholders of lululemon:In support of all shareholders, I am pursuing a campaign to catalyze a quantum of change that is sorely needed at lululemon. To effect that change, I have pursued private, constructive dialogues with the lululemon Board of Directors (the "Board") for the past few months. My attempts toward a sensible solution have not been reciprocated.The heart of the issue is a disconnect between the Company's creative engine and the Board's str

    2/27/26 8:00:00 AM ET
    $LULU
    Apparel
    Consumer Discretionary

    Nasdaq Executives to Present at Upcoming Investor Conferences

    NEW YORK, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Nasdaq (NASDAQ:NDAQ) will be presenting at the following conferences in March with webcasts available at Nasdaq's Investor Relations website: https://ir.nasdaq.com/. Who:Sarah Youngwood, Executive Vice President & Chief Financial Officer, NasdaqWhat:Morgan Stanley Technology, Media & Telecom ConferenceWhen:Monday, March 2nd, 11:30 AM ET  Who:Jeremy Skule, Executive Vice President, Chief Strategy Officer & Executive Chair, Financial Crime Management Technology, NasdaqWhat:Raymond James 47thAnnual Institutional Investors ConferenceWhen:Wednesday, March 4th, 8:05 AM ET   About NasdaqNasdaq (NASDAQ:NDAQ) is a leading technology platform that powers t

    2/26/26 5:00:00 PM ET
    $NDAQ
    Investment Bankers/Brokers/Service
    Finance

    $ALNY
    $BIIB
    $CDW
    $FER
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for VUMERITY issued to BIOGEN INC

    Submission status for BIOGEN INC's drug VUMERITY (ORIG-1) with active ingredient DIROXIMEL FUMARATE has changed to 'Approval' on 09/12/2024. Application Category: NDA, Application Number: 761347, Application Classification: Type 3 - New Dosage Form

    9/16/24 6:52:10 AM ET
    $BIIB
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    FDA Approval for VUMERITY issued to BIOGEN INC

    Submission status for BIOGEN INC's drug VUMERITY (SUPPL-17) with active ingredient DIROXIMEL FUMARATE has changed to 'Approval' on 09/11/2024. Application Category: NDA, Application Number: 211855, Application Classification: Manufacturing (CMC)

    9/16/24 6:24:32 AM ET
    $BIIB
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    FDA Approval for GIVLAARI issued to ALNYLAM PHARMS INC

    Submission status for ALNYLAM PHARMS INC's drug GIVLAARI (SUPPL-7) with active ingredient GIVOSIRAN SODIUM has changed to 'Approval' on 04/29/2024. Application Category: NDA, Application Number: 212194, Application Classification: Labeling

    4/30/24 1:44:03 PM ET
    $ALNY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ALNY
    $BIIB
    $CDW
    $FER
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    The Trade Desk downgraded by New Street with a new price target

    New Street downgraded The Trade Desk from Neutral to Sell and set a new price target of $17.00

    2/26/26 7:12:57 AM ET
    $TTD
    Computer Software: Programming Data Processing
    Technology

    The Trade Desk downgraded by Loop Capital with a new price target

    Loop Capital downgraded The Trade Desk from Buy to Hold and set a new price target of $25.00

    2/26/26 7:11:50 AM ET
    $TTD
    Computer Software: Programming Data Processing
    Technology

    NASDAQ upgraded by TD Cowen with a new price target

    TD Cowen upgraded NASDAQ from Hold to Buy and set a new price target of $106.00

    2/26/26 7:10:22 AM ET
    $NDAQ
    Investment Bankers/Brokers/Service
    Finance

    $ALNY
    $BIIB
    $CDW
    $FER
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Legal Officer & Corp Sec Tregillis Cynthia L converted options into 6 shares, covered exercise/tax liability with 770 shares and sold $61,228 worth of shares (214 units at $286.11), decreasing direct ownership by 0.73% to 133,781 units (SEC Form 4)

    4 - WESTERN DIGITAL CORP (0000106040) (Issuer)

    2/27/26 4:57:59 PM ET
    $WDC
    Electronic Components
    Technology

    Chief Executive Officer Tan Irving converted options into 27 shares and covered exercise/tax liability with 425 shares, decreasing direct ownership by 0.06% to 622,563 units (SEC Form 4)

    4 - WESTERN DIGITAL CORP (0000106040) (Issuer)

    2/27/26 4:57:51 PM ET
    $WDC
    Electronic Components
    Technology

    Chief of Global Operations Gubbi Vidyadhara K converted options into 7 shares and covered exercise/tax liability with 1,010 shares, decreasing direct ownership by 0.80% to 124,949 units (SEC Form 4)

    4 - WESTERN DIGITAL CORP (0000106040) (Issuer)

    2/27/26 4:57:45 PM ET
    $WDC
    Electronic Components
    Technology

    $ALNY
    $BIIB
    $CDW
    $FER
    SEC Filings

    View All

    SEC Form DEFA14A filed by lululemon athletica inc.

    DEFA14A - lululemon athletica inc. (0001397187) (Filer)

    2/27/26 5:19:59 PM ET
    $LULU
    Apparel
    Consumer Discretionary

    SEC Form 10-K filed by Monolithic Power Systems Inc.

    10-K - MONOLITHIC POWER SYSTEMS INC (0001280452) (Filer)

    2/27/26 4:33:25 PM ET
    $MPWR
    Semiconductors
    Technology

    Monolithic Power Systems Inc. filed SEC Form 8-K: Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review

    8-K - MONOLITHIC POWER SYSTEMS INC (0001280452) (Filer)

    2/27/26 4:31:27 PM ET
    $MPWR
    Semiconductors
    Technology

    $ALNY
    $BIIB
    $CDW
    $FER
    Leadership Updates

    Live Leadership Updates

    View All

    Chip Wilson Provides Update to lululemon Shareholders

    VANCOUVER, BC, Feb. 27, 2026 /CNW/ -- Chip Wilson, Founder of lululemon athletica inc. (NASDAQ:LULU) ("lululemon" or the "Company") and one of lululemon's largest shareholders, today released the following letter to lululemon shareholders: Shareholders of lululemon:In support of all shareholders, I am pursuing a campaign to catalyze a quantum of change that is sorely needed at lululemon. To effect that change, I have pursued private, constructive dialogues with the lululemon Board of Directors (the "Board") for the past few months. My attempts toward a sensible solution have not been reciprocated.The heart of the issue is a disconnect between the Company's creative engine and the Board's str

    2/27/26 8:00:00 AM ET
    $LULU
    Apparel
    Consumer Discretionary

    The Trade Desk Introduces the Ventura Ecosystem to Advance the Future of CTV Advertising; V and Nexxen Join as the First Collaborators

    The Ventura Ecosystem aims to unite global TV operating systems and industry partners to create a more transparent, collaborative, and revenue-optimized marketplace for CTV advertising Today, The Trade Desk's Ventura, the platform built for a fairer and more transparent streaming ecosystem, takes the next step in its vision to optimize programmatic advertising in connected TV (CTV) with the launch of the Ventura Ecosystem. The Ventura Ecosystem is an industry collaboration that brings global TV operating systems and streaming platforms together to create a more transparent and revenue‑optimized marketplace, so the industry can continue to grow and thrive. Through the Ventura Ecosystem, pa

    2/24/26 9:00:00 AM ET
    $TTD
    Computer Software: Programming Data Processing
    Technology

    GlobalFoundries Appoints Ganesh Moorthy to Board of Directors

    MALTA, N.Y., Jan. 15, 2026 (GLOBE NEWSWIRE) -- GlobalFoundries (NASDAQ:GFS) (GF) today announced the appointment of Ganesh Moorthy to its board of directors. Mr. Moorthy, former president and CEO of Microchip Technology Inc., joins GF's Board, effective immediately. Mr. Moorthy brings more than four decades of experience in the semiconductor industry, including transformative leadership at Microchip Technology, where he served as CEO, president and board member until his retirement in November 2024. He was appointed CEO and president in March 2021 and joined Microchip's Board of Directors in January 2021. Prior to that, he held senior leadership roles at Microchip including COO and execut

    1/15/26 8:30:00 AM ET
    $GFS
    Semiconductors
    Technology

    $ALNY
    $BIIB
    $CDW
    $FER
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Torgeby Johan bought $958,320 worth of shares (12,000 units at $79.86), increasing direct ownership by 42% to 40,797 units (SEC Form 4)

    4 - NASDAQ, INC. (0001120193) (Issuer)

    2/19/26 4:00:18 PM ET
    $NDAQ
    Investment Bankers/Brokers/Service
    Finance

    Head of Pharm Ops and Tech Murphy Nicole bought $585 worth of shares (3 units at $195.03), increasing direct ownership by 0.02% to 19,611 units (SEC Form 4)

    4 - BIOGEN INC. (0000875045) (Issuer)

    2/17/26 8:16:40 PM ET
    $BIIB
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Large owner Investor Ab bought $15,835,040 worth of shares (200,000 units at $79.18) (SEC Form 4)

    4 - NASDAQ, INC. (0001120193) (Issuer)

    2/13/26 3:56:39 PM ET
    $NDAQ
    Investment Bankers/Brokers/Service
    Finance

    $ALNY
    $BIIB
    $CDW
    $FER
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by The Trade Desk Inc.

    SC 13G/A - Trade Desk, Inc. (0001671933) (Subject)

    11/14/24 4:42:28 PM ET
    $TTD
    Computer Software: Programming Data Processing
    Technology

    Amendment: SEC Form SC 13G/A filed by Insmed Incorporated

    SC 13G/A - INSMED Inc (0001104506) (Subject)

    11/14/24 1:22:37 PM ET
    $INSM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Western Digital Corporation

    SC 13G/A - WESTERN DIGITAL CORP (0000106040) (Subject)

    11/14/24 1:22:34 PM ET
    $WDC
    Electronic Components
    Technology

    $ALNY
    $BIIB
    $CDW
    $FER
    Financials

    Live finance-specific insights

    View All

    Ferrovial reports strong full-year 2025 results, boosted by robust performance in all businesses

    The company posted a 12.2% increase in adjusted EBITDA1, thanks to higher contributions from Highways and ConstructionStrong cash generation supported by dividends from infrastructure projects and asset rotationAMSTERDAM, Feb. 25, 2026 /PRNewswire/ -- Ferrovial, a leading global infrastructure company, today reported financial results for the full year 2025. Ferrovial closed the year with significant growth, supported by a substantial increase in revenue and adjusted EBITDA1 in all businesses, primarily North American highways and Construction. Strong cash flow generation was supported by dividends from infrastructure projects and asset rotation.

    2/25/26 6:42:00 PM ET
    $FER
    Military/Government/Technical
    Industrials

    The Trade Desk Reports Fourth Quarter and Fiscal Year 2025 Financial Results

    The Trade Desk also announced an additional share repurchase authorization, bringing the total amount of authorized future repurchases to $500 million of its Class A common stock. The Trade Desk, Inc. ("The Trade Desk," the "Company" or "we") (NASDAQ:TTD), a provider of a global technology platform for buyers of advertising, today announced financial results for its fourth quarter and fiscal year ended December 31, 2025. "The Trade Desk delivered $2.9 billion in revenue in 2025 while continuing to generate significant profitability and cash flow," said Jeff Green, Co-Founder and CEO of The Trade Desk. "We executed against a backdrop of macro uncertainty while making some of the most mea

    2/25/26 4:01:00 PM ET
    $TTD
    Computer Software: Programming Data Processing
    Technology

    Insmed Reports Fourth-Quarter and Full-Year 2025 Financial Results and Provides Business Update

    —Company Expects Full-Year 2026 BRINSUPRI® (brensocatib) Revenues to Be at Least $1 Billion; Reiterates Full-Year 2026 ARIKAYCE® (amikacin liposome inhalation suspension) Revenue Guidance of $450 Million to $470 Million——Total Company Revenues of $606.4 Million for Full-Year 2025——BRINSUPRI Total Revenues of $144.6 Million for Fourth-Quarter and $172.7 Million for Full-Year 2025——ARIKAYCE Total Revenues of $119.2 Million for Fourth-Quarter and $433.8 Million for Full-Year 2025, Representing 19% Annual Growth and Exceeding the Upper End of Full-Year 2025 Guidance——Topline Data Readouts from Phase 3 ENCORE and Phase 2b CEDAR Studies Remain on Track——FDA grants Orphan Drug Designation to Trepro

    2/19/26 7:00:00 AM ET
    $INSM
    Biotechnology: Pharmaceutical Preparations
    Health Care